• More education, time and money were needed to address this growing healthcare burden.
Three years on and we now have a new contract, which some claim has reduced rather than increased the available resources. Complex periodontal care appears within band 2, translates to three UDAs or anywhere between £45 and £90 per course of treatment, relative to £100 under the old item 10c in the fee-per-item system. So much for progress…or is it?
The admirable philosophy underpinning the new contract was one in which prevention became the mainstay of 21st century NHS dentistry, rather than a fee structure which encouraged intervention and gave no fi nancial recognition for diagnosis, risk management and preventative care strategies. This is a medical model rather than a surgical model and is rapidly emerging in the USA as the 'wellness model'. The idea is, you measure wellness, analyse risk for common diseases and re-distribute your resources to focus on those who need it most, rather than the 'repair model', where you fi x it when it breaks. In the short to medium term, the patient and practitioner win, and in the longer term the funders also win. But the Department of Health (DoH) stopped short of full capitation because of the justifi able concerns that this may lead to supervised neglect in some cases. The result was a compromise, which inevitably had to involve some 'bean counting' to ensure activity levels were being maintained to justify the agreed GDP contract costs. However, just as the DoH needed to bean count, so did the general dental practitioner. The admirable philosophy behind the new contract became clouded by fi nancial wrangling and a degree of discontent. The problem is that UK dentistry may not yet be ready for this huge philosophical leap, and many dentists are understandably suspicious of an underlying government agenda of costcutting. The following extract is typical of referrals now received for specialist periodontal care since the new contract was introduced: 'Dear Sir, …on the new NHS regulations it would appear that I will only get 1 UDA for all the periodontal treatment and the practice owner has advised that it is totally uneconomical for us to treat the patient'. So where do we go from here?
Management of periodontal diseases within the NHS three years on: are things any better?
This paper will begin by briefl y analysing the provision of periodontal care under the old and new contracts and introduce the concept of medical management formulas under the 'wellness model' rather than the traditional surgical approach that comprises the 'repair model' . A new online risk (and disease) calculator 'PreViser' developed in the United States and now available in the UK (Previser.co.uk) will be presented as an example of how UK Dentists can start working towards adopting the wellness model in modern preventative care practices. The presentation will then discuss the myths and realities surrounding one-stage full mouth disinfection, and ask how strong the evidence is for benefi t, before taking a look into the future of novel host-modulation therapies and demonstrating What about the time it takes to treat moderate to severe periodontitis? The data I presented in 2004 indicated that UK experts estimated average treatment times necessary to appropriately manage moderate periodontitis at ≥4 hours, yet most GDPs were only able to spend one hour due to the remuneration associated with the old 'item 10c'. Marc Quirynen et al.'s landmark paper of 1995, 1 which re-visited the concept of full mouth periodontal therapy within 24 hours, set a hare running and since then over 15 studies have been published on onestage full-mouth disinfection, or related treatment strategies. Inevitably, these have been misinterpreted and misrepresented. Indeed, some practitioners take the view that we now have evidence that periodontal therapy performed over four hours can be provided equally as successfully through a one hour full mouth ultrasonic debridement! Does this solve the fi nancial problem? I shall attempt to answer this question and other related issues in Harrogate.
The future…
What of future novel technologies for managing a host-modulated disease like periodontitis? Is there a role for pre-or probiotics? Do these represent a paradigm technological shift in our approach to therapy?
Finally, what of the micronutrient approach? I shall present defi nitive data from a large epidemiological study by our group, which demonstrates clear negative associations between blood antioxidant levels and periodontitis prevalence. Can some of these novel micronutrients really control gene expression and down-regulate infl ammation at a sub-cellular level? The answer from our own research is yes. But will this translate into clinical benefi t and are they a practical supplemental periodontal therapy? I shall spend the last 15 minutes of my presentation taking a brief look into the exciting future of host-modulating therapies.
I look forward to sharing some thoughts with you, to a little controversy and some heated debate…that's the plan anyhow.
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